SARS-CoV-2 diagnostic testing alternatives for Latin America

Fuente: Redalyc
Salvato in:
Dettagli Bibliografici
Autore principale: Julián Santaella-Tenorio
Natura: Artículo científico
Lingua:en
Pubblicazione: Universidad del Valle 2020
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1876482191096020992
author Julián Santaella-Tenorio
author_facet Julián Santaella-Tenorio
contents SARS-CoV-2 diagnostic testing alternatives for Latin America Julián Santaella-Tenorio Medicina 19 CoV SARS COVID drugs In the past four months SARS-CoV-2 has reached most countries in the world. Public health strategies based on widespread testing and proper isolation of positive cases have shown to be helpful to reduce local transmission of SARS-CoV-2. Confirmatory tests, that identify viral RNA, and screening serological tests that identify viral antigens or host antibodies against viral proteins are part of the tools that nations can use to fight infectious disease epidemics. Understanding how each test works can provide insights about their test characteristics and how they can be used for different clinical and public health goals. Testing is a key strategy to reduce viral transmission, not only for this epidemic, but also for others to come. 2020 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28364445004 https://www.redalyc.org/journal/283/28364445004/ https://www.redalyc.org/journal/283/28364445004/html/ https://www.redalyc.org/journal/283/28364445004/28364445004.epub https://www.redalyc.org/journal/283/28364445004/movil 10.25100/cm.v51i2.4272 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.2 Vol.51
format Artículo científico
id redalyc_28364445004
institution Redalyc
language en
publishDate 2020
publisher Universidad del Valle
spellingShingle SARS-CoV-2 diagnostic testing alternatives for Latin America
Julián Santaella-Tenorio
Medicina
19
CoV
SARS
COVID
drugs
SARS-CoV-2 diagnostic testing alternatives for Latin America Julián Santaella-Tenorio Medicina 19 CoV SARS COVID drugs In the past four months SARS-CoV-2 has reached most countries in the world. Public health strategies based on widespread testing and proper isolation of positive cases have shown to be helpful to reduce local transmission of SARS-CoV-2. Confirmatory tests, that identify viral RNA, and screening serological tests that identify viral antigens or host antibodies against viral proteins are part of the tools that nations can use to fight infectious disease epidemics. Understanding how each test works can provide insights about their test characteristics and how they can be used for different clinical and public health goals. Testing is a key strategy to reduce viral transmission, not only for this epidemic, but also for others to come. 2020 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28364445004 https://www.redalyc.org/journal/283/28364445004/ https://www.redalyc.org/journal/283/28364445004/html/ https://www.redalyc.org/journal/283/28364445004/28364445004.epub https://www.redalyc.org/journal/283/28364445004/movil 10.25100/cm.v51i2.4272 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.2 Vol.51
title SARS-CoV-2 diagnostic testing alternatives for Latin America
topic Medicina
19
CoV
SARS
COVID
drugs
url https://www.redalyc.org/articulo.oa?id=28364445004
https://www.redalyc.org/journal/283/28364445004/
https://www.redalyc.org/journal/283/28364445004/html/
https://www.redalyc.org/journal/283/28364445004/28364445004.epub
https://www.redalyc.org/journal/283/28364445004/movil